Eisai Co., Ltd.

Informe acción OTCPK:ESAL.Y

Capitalización de mercado: US$17.7b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Eisai Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Información clave

1.1%

Tasa de crecimiento de los beneficios

1.0%

Tasa de crecimiento del BPA

Crecimiento de la industria Pharmaceuticals 6.0%
Tasa de crecimiento de los ingresos5.1%
Rentabilidad financiera3.6%
Margen neto4.3%
Próxima actualización de resultados06 Feb 2023

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Eisai. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

OTCPK:ESAL.Y Ingresos, gastos y beneficios (JPY Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Sep 22752,50032,233382,752173,324
30 Jun 22741,59432,690374,428168,422
31 Mar 22756,22647,954356,847171,738
31 Dec 21712,93557,311317,150165,418
30 Sep 21691,25062,508293,153162,699
30 Jun 21679,25359,855282,369161,584
31 Mar 21645,94242,119272,568150,299
31 Dec 20707,88893,682271,476145,248
30 Sep 20713,400120,571261,973139,628
30 Jun 20707,203124,523253,516141,217
31 Mar 20695,621121,767248,554140,116
31 Dec 19661,64696,659244,091146,367
30 Sep 19631,97457,725239,503147,863
30 Jun 19643,53172,747233,180140,143
31 Mar 19642,83463,386223,798144,844
31 Dec 18627,36763,714212,469139,100
30 Sep 18625,10665,679195,229138,461
30 Jun 18611,49954,347186,198140,514
31 Mar 18600,05451,845179,915139,579
31 Dec 17569,81429,048178,312134,955
30 Sep 17554,27630,269178,090123,639
30 Jun 17544,02729,425176,249119,503
31 Mar 17539,09739,358175,633112,478
31 Dec 16530,69655,031175,240110,471
30 Sep 16542,31371,812178,825114,420
30 Jun 16545,60269,227182,036115,750
31 Mar 16547,92254,933188,227122,307

Ingresos de calidad: ESAL.Y has a large one-off gain of ¥13.4B impacting its September 30 2022 financial results.

Margen de beneficios creciente: ESAL.Y's current net profit margins (4.3%) are lower than last year (9%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: ESAL.Y's earnings have grown by 1.1% per year over the past 5 years.

Acelerando crecimiento: ESAL.Y's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Beneficios vs. Industria: ESAL.Y had negative earnings growth (-48.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (7%).

Rentabilidad financiera

Alta ROE: ESAL.Y's Return on Equity (3.6%) is considered low.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

7D

1Y

7D

1Y

7D

1Y